WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹338 Cr | ₹298 Cr | ₹347 Cr | ₹284 Cr | ₹275 Cr |
What is the latest Total Liabilities ratio of WANBURY ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹338 Cr |
Mar2023 | ₹298 Cr |
Mar2022 | ₹347 Cr |
Mar2021 | ₹284 Cr |
Mar2020 | ₹275 Cr |
How is Total Liabilities of WANBURY Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹338 Cr | 13.41 | |
Mar2023 | ₹298 Cr | -14.09 | |
Mar2022 | ₹347 Cr | 22.35 | |
Mar2021 | ₹284 Cr | 2.98 | |
Mar2020 | ₹275 Cr | - |
Compare Total Liabilities of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹952.6 Cr | 6.1% | 16.1% | 43.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,498.0 Cr | 1.9% | -2.1% | -6.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹165,838.0 Cr | 2.7% | -5.6% | 25.2% | Stock Analytics | |
CIPLA | ₹129,330.0 Cr | 3.4% | 7.7% | 0.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,235.0 Cr | 0.6% | 4.4% | 9.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,211.0 Cr | 3.2% | 1.6% | -8.4% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | 6.1% |
16.1% |
43.7% |
SENSEX | 0.5% |
-1.3% |
0.9% |
You may also like the below Video Courses